Printer Friendly

Actavis unveils generic Celebrex for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis & acute pain.

M2 EQUITYBITES-December 11, 2014-Actavis unveils generic Celebrex for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis & acute pain

(C)2014 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical company Actavis (NYSE:ACT) reported on Wednesday the market availability of generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules under a settlement agreement with Pfizer.

The company said Celebrex is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis as well as for the management of acute pain in adults.

According to IMS Health data, Celebrex had US sales of approximately USD2.4bn for the 12-month period ending 30 June 2014.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Dec 11, 2014
Words:119
Previous Article:UniSource Energy Acquires Stake in Gas-Fired Power Station in USA.
Next Article:Relmada Therapeutics hires Christine Silverstein as director of Investor Relations.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters